Growing community of inventors

Seoul, South Korea

Mi Ra Yu

Average Co-Inventor Count = 5.05

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Mi Ra YuHea Ok Kim (3 patents)Mi Ra YuChong Woo Park (2 patents)Mi Ra YuSang Koo Lee (2 patents)Mi Ra YuBo Mi Park (2 patents)Mi Ra YuChong-Woo Park (2 patents)Mi Ra YuHee Woo Lee (2 patents)Mi Ra YuJae Wook Yang (1 patent)Mi Ra YuHyuk Woo Lee (1 patent)Mi Ra YuJi Youn Lee (1 patent)Mi Ra YuJee Young Kim (1 patent)Mi Ra YuMi Ra Yu (4 patents)Hea Ok KimHea Ok Kim (5 patents)Chong Woo ParkChong Woo Park (3 patents)Sang Koo LeeSang Koo Lee (3 patents)Bo Mi ParkBo Mi Park (2 patents)Chong-Woo ParkChong-Woo Park (2 patents)Hee Woo LeeHee Woo Lee (2 patents)Jae Wook YangJae Wook Yang (10 patents)Hyuk Woo LeeHyuk Woo Lee (6 patents)Ji Youn LeeJi Youn Lee (2 patents)Jee Young KimJee Young Kim (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Future Medicine Co., Ltd. (4 from 5 patents)


4 patents:

1. 12083140 - Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative

2. 12076334 - Pharmaceutical composition comprising adenosine derivative for prevention and treatment of retinal disease or optic nerve disease

3. 11266644 - Pharmaceutical composition for preventing and treating diabetic nephropaphy including adenosine derivative

4. 11185556 - Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…